Viamet Pharmaceuticals, Inc.

Release Summary

Viamet Pharma announces that results from RENOVATE, its Phase 2b trial of VT-1161 for onychomycosis of the toenail, will be presented at the American Academy of Dermatology 2017 Annual Meeting

Viamet Pharmaceuticals, Inc.